Copyright
©The Author(s) 2024.
World J Clin Oncol. Jun 24, 2024; 15(6): 695-716
Published online Jun 24, 2024. doi: 10.5306/wjco.v15.i6.695
Published online Jun 24, 2024. doi: 10.5306/wjco.v15.i6.695
Serial No. | Sample size | Findings | Ref. |
1 | GBC (214) controls (214) | Biomass burning was recognized as a significant risk factor for GBC | Shridhar et al[20] |
2 | GBC (200); Gall stone disease (200) controls (200) | Residence in the Gangetic belt, consumption of tea, tobacco, joint family structure, chemical exposure, fried food, and high levels of secondary bile salts are risk factors of GBC | Jain et al[21] |
3 | GBC (54) | Cholelithiasis is a predisposing factor for GBC | Bhattacharjee and Nanda[22] |
4 | GBC (1291) | Exposure to high soil arsenic levels and proximity to river ganga are risk factors for GBC | Madhawi et al[23] |
5 | GBC (333) | Smoking, cholelithiasis, alcohol consumption, typhoid in the past, post-menopausal women are risk factors for GBC | Tyagi et al[24] |
6 | GBC (63) | Poor hygiene and water supply, malnutrition, cholelithiasis, tobacco and alcohol consumption are modifiable risk factors for GBC | Khan et al[25] |
7 | GBC (122); controls (122) | Education, intake of vitamin C, parity, and type of fuel used were significant factors for GBC | Panda et al[26] |
8 | GBC (49) | About 75% of patients diagnosed with GSD showed detectable H. pylori DNA in their gallbladder tissue | Bansal et al[27] |
9 | GSD (330) | As the stone size increases, gallbladder mucosa changes progress from cholecystitis to carcinoma | Mathur et al[28] |
10 | GBC (n = 11), Chronic cholecystitis (n = 23), Xantho-granulomatous cholecystitis (n = 11) | The cholesterol content in gallstones of GBC was significantly lower compared to that in benign gallbladder diseases | Srivastava et al[29] |
11 | GBC (390) | Chronic bacterial infection of bile is considered an etiological factor in the development of gallbladder carcinoma | Sharma et al[30] |
12 | GSD (101) | H. pylori colonizes regions of gastric metaplasia within the gallbladder | Misra et al[31] |
13 | GBC (328); controls (328) | Females, consumption of mustard oil, Family history, low socioeconomic status and drinking water from hand pump were the risk factors for GBC | Kumar et al[32] |
14 | GBC (27), GSD (196) | High prevalence of salmonella typhi in gall bladder carcinoma | Vaishnavi et al[33] |
15 | GBC (38) | Higher levels of biliary nitrate associated with the gallbladder carcinogenesis | Shukla et al[34] |
16 | GBC (n = 30); controls (n = 30) | Decreased levels of selenium (Se), zinc (Zn), and vitamin E are associated with an increased risk of gallbladder carcinoma | Shukla et al[35] |
17 | GBC (n = 30); controls (n = 30) | Significantly high biliary benzene hexachloride and dichloro diphenyl trichloroethane associated with gallbladder carcinogenesis | Shukla et al[36] |
18 | 150 GBC | Gall stones associated with development of metaplastic, dysplastic and neoplastic mucosal changes of gall bladder mucosa | Gupta et al[37] |
Serial No. | Sample size | Findings | Ref. |
1 | - | IGF-MAPK cascade, p38 MAPK pathway, p53 pathway, and FAS signaling pathway as highly enriched among dysregulated miRNAs in GBC | Saxena et al[51] |
2 | - | PARP1 rs1136410 (A/G) associated with early onset of GBC | Anjali et al[52] |
3 | GBC (29), controls (29) | VEGF-A expression can be used as potential prognostic biomarker in GBC | Singh et al[53] |
4 | - | Studied the prognostic significance of the oxidative stress marker 8-OH-dG and genes associated with the BER pathway | Singh et al[54] |
5 | GBC (25) | In gallbladder cancer patients, mutations were identified in both P53 and codon 12 of KRAS | Shukla et al[55] |
6 | - | Mutations in the sorcin gene associated with poor overall survival in GBC | Shabnam et al[56] |
7 | GBC (523), controls (274) | Studied the TERT-CLPTM1L and 8q24 Genetic Variants in GBC | Yadav et al[57] |
8 | GBC (50) | Individual and repetitive mutations of shh gene in GBC can be used as diagnostic marker | Dixit et al[58] |
9 | GBC (50) | Overexpression of Her2/neu and Ki67 in gallbladder cancer associated with lymph node metastasis | Pujani et al[59] |
10 | GBC (541), controls (307) | KRAS rs61764370 polymorphism is significantly associated with GBC | Kazmi et al[60] |
11 | - | Studied Epigenetic silencing of APC in advanced GBC. | Tekcham et al[61] |
12 | GBC (24) | Found 7 hypermethylated or down-regulated (e.g., FBN1, LPP, and SOD3) and 61 hypomethylated or up-regulated markers (e.g., HBE1, SNRPF, TPD52) for GBC | Sharma et al[62] |
13 | Cases (50) | The level of EGFR expression correlates with the aggressiveness of the disease | Kumar et al[63] |
14 | GBC (52) | Tγδ17 could serve as a potential predictive biomarker in GBC | Patil et al[64] |
15 | GBC (30) | The MTHFR A1298C polymorphism associated with development of GBC | Dixit et al[65] |
16 | GBC (37) | Telomere dysfunction and alterations are the earlier events in progression of GBC | Poojary et al[66] |
17 | GBC (148), controls (256) | CYP-17 gene polymorphism is associated with risk of gallbladder cancer | Dwivedi et al[67] |
18 | - | LXR-β polymorphisms associated with GBC | Sharma et al[68] |
19 | GBC (195), controls (300) | Vascular endothelial growth factor single nucleotide polymorphism associated with GBC | Mishra et al[69] |
20 | GBC (35) | mitochondrial D-loop mutation associated with GBC | Maurya et al[70] |
21 | GBC (410), controls (210) | Estrogen and progesterone receptor sequence associated with increased risk of GBC | Srivastava et al[71] |
22 | - | KRAS p.Q25H polymorphism associated with development of GBC | Parmanik et al[72] |
23 | GBC (230), controls (230) | Caspase-8 polymorphisms associated with GBC | Srivastava et al[73] |
24 | GBC (51) | p53 mutation are early events in the evolution of GBC | Agrawal et al[74] |
25 | GBC (185), controls (195) | CYP7A1 haplotype associated with GBC | Srivastava et al[75] |
26 | GBC (230), controls (230) | The role of pre-microRNA variants in GBC uncertain | Srivastava et al[76] |
27 | GBC (62) | Most common alteration in the p53 was frameshift mutation at codon 271 | Nigam et al[77] |
28 | GBC (40) | High LOH in CDH1 associated with pathogenesis of GBC | Priya et al[78] |
29 | GBC (212), controls (219) | Studied the DNMT3B -579 G > T promoter polymorphism | Srivastava et al[79] |
30 | GBC (233), controls (260) | Angiotensin I-converting enzyme insertion/deletion polymorphism associated with GBC | Srivastava et al[80] |
31 | GBC (126), controls (190) | Role of DNA repair pathways GB carcinogenesis | Srivastava et al[81] |
32 | GBC (171), controls (221) | Patients with ABCG8 variant allele are at a higher risk of GBC | Srivastava et al[82] |
33 | GBC (185), controls (200) | Complement receptor polymorphism associated with pathogenesis of GBC | Srivastava and Mittal[83] |
34 | GBC (173), controls (204) | Single nucleotide polymorphisms of DNA repair genes OGG1 and XRCC1; associated with low risk for GBC | Srivastava et al[84] |
35 | GBC (144), controls (210) | Role of CCR5+/Delta32 polymorphism associated with risk of GBC | Srivastava et al[85] |
36 | GBC (124), controls (166) | IL-1 gene polymorphisms associated with GBC | Vishnoi et al[86] |
37 | GBC (142), controls (217) | CYP1A1 C allele frequency associated with GBC | Pandey et al[87] |
38 | - | CYP7A1 polymorphism associated with GBC | Srivastava et al[88] |
39 | - | The X (+), D haplotype of APOB is associated risk for development of GBC | Pandey et al[89] |
40 | - | NAT2 slow acetylator phenotype associated with risk of GBC | Pandey et al[90] |
41 | GBC (129), controls (208) | LRPAP1 polymorphism associated with GBC | Pandey et al[91] |
42 | GBC (39) | Mutation in codon 12 of the K-ras oncogene associated with GBC, which indicate role of chronic inflammation in gallbladder carcinogenesis. | Singh et al[92] |
43 | GBC (117), controls (137) | The apoB-XbaI gene polymorphism associated with GBC | Singh et al[93] |
Serial No. | Sample size | Findings | Ref. |
1 | GBC (50) | Her2 neu, p53, p16, survivin, COX-2, and EZH-2 expression associated with GBC | Gupta et al[115] |
2 | GBC (200), Dysplasia (32), CC (100) | HER-2/neu overexpression seen in patients with GBC | Jain et al[116] |
3 | GBC (128) | HER 2 and Ki-67 can be used as a prognostic biomarker for gallbladder carcinoma | Halder et al[117] |
4 | - | Combination of ALU247 and cfDNA provides good sensitivity, specificity in diagnosis of GBC | Kumari et al[118] |
5 | - | Proposed a scoring system for XGC | Rajaguru et al[119] |
6 | GBC (34) | Quantitative analysis of cfDNA may aid in early diagnosis | Kumari et al[120] |
7 | GBC (39), cholelithiasis (30), and control (25) | Overexpression of survivin is associated with poor prognosis | Nigam et al[121] |
8 | (GSD, n =30; GBC, n = 39) healthy control (n = 25) | Expression of survivin in peripheral blood could be useful both in the diagnosis and prognosis of GBC | Nigam et al[122] |
9 | GBC (80) | P53 expression is positively correlated with increasing tumor grade, whereas beta-catenin nuclear expression is associated with tumor grade and depth of invasion | Ghosh et al[123] |
10 | 9 case of Squamous cell carcinoma | Ultrasound-guided fine-needle aspiration is a useful minimally invasive investigation in the preoperative diagnosis of squamous cell carcinoma of the gallbladder | Gupta and Gupta[124] |
11 | GBC (55), vontrols (8) | Assay of CA242, CA19-9, CA15-3, and CA125 can be used as marker of carcinoma of the gallbladder | Shukla et al[125] |
12 | GBC (40) | Intraoperative bile cytology can be used for diagnosis of in situ and early invasive GBC | Arora et al[126] |
Serial No. | Sample size | Findings | Ref. |
1 | - | PET-CT can be used to rule out metastatic disease and for post-therapy surveillance for recurrence in patients of GBC | Bisht et al[147] |
2 | GBC (38) | Potential utility of CT texture-based radiomics analysis in patients with GBC. | Gupta et al[148] |
3 | GBC (141) | Raised levels of serum CA19-9 beyond 20 units/mL should be used for prognostication purposes after EC | Agrawal et al[149] |
4 | GBC (141) | NMR-based methods can be used as a diagnostic modality for GBC | Sharma et al[150] |
5 | GBC (41) | CEA expression may help in diagnosis of GBC | Mondal et al[151] |
6 | GBC (203) | Discontinuous mucosal lining, diffuse wall thickening, intramural nodules, and cholelithiasis may indicate XGC rather than gallbladder carcinoma | Sureka et al[152] |
7 | GBC (74) | Duodenal involvement significantly decreases resectability but does not preclude resection | Kalayarasan et al[153] |
8 | XGC (31) | Mass-forming XGC mimics GBC | Agarwal et al[154] |
9 | GBC (117) | CA 242 is a promising tumor marker for GBC and performs better than CEA and CA19-9. | Rana et al[155] |
10 | GBC (15) | Dynamic MRI with MRCP is a reliable method of showing gall bladder carcinoma. | Kaza et al[156] |
11 | GBC (60) | Color Doppler USG together can improve pickup rate of GBC | Pradhan et al[157] |
Serial No. | Sample size | Findings | Ref. |
1 | GBC (521) | Surgical resection improves survival in GBC with jaundice | Goel et al[186] |
2 | GBC (97) | Radical cholecystectomy with wedge resection of the liver oncological equivalence compared to formal segment IVb/V excision | Patkar et al[187] |
3 | GBC (20) | The technique of LHBRL is safe and feasible for patients with GBC | Nag et al[188] |
4 | 07 incidental GBC | Re-exploration and aggressive resection followed by adjuvant chemotherapy for incidental gallbladder carcinoma are safe and provide hope for long-term survival | Kaman et al[189] |
Serial No. | Sample size | Findings | Ref. |
1 | GBC (176) | CT followed by CTRT improves outcomes in patients with limited volume disease | Alam et al[205] |
2 | GBC (550) | CT followed by cCTRT appears to improve survival in responders with good PS | Alam et al[206] |
3 | GBC (38) | Her2neu directed therapy significantly improved survival | Das et al[207] |
4 | GBC (66) | FOLFOX-4 is an effective and well-tolerated regimen as a second-line treatment | Dodagoudar et al[208] |
5 | GBC (87) | CAP-IRI is a well-tolerated second-line chemotherapeutic regimen in advanced GBC | Ramaswamy et al[209] |
6 | GBC (121) | Reduced dose intensity of chemotherapy in GBC | Gangopadhyay et al[210] |
7 | GBC (210) | Use of gem-platinum in Indian patients associated with slightly worse outcomes | Sirohi et al[211] |
8 | - | Autologous immune enhancement therapy associated with, an improvement of the quality of life | Bhamare et al[212] |
9 | GBC (104) | Adjuvant chemoradiation improve survival | Mallick et al[213] |
10 | - | Chemoradiation improve survival in locally advanced GBC | Engineer et al[214] |
Serial No. | Sample size | Findings | Ref. |
1 | GBC (510) | Surgery and peri-operative systemic therapy associated with improved survival | Patkar et al[218] |
2 | GBC (28) | Locally advanced GBC may benefit from neoadjuvant chemoradiation | Engineer et al[219] |
3 | GBC (37) | Neoadjuvant chemotherapy in patients with locally advanced gallbladder cancer | Sirohi et al[220] |
4 | GBC (21) | Resection after neoadjuvant chemotherapy improve survival | Selvakumar et al[221] |
- Citation: Kumar A, Sarangi Y, Gupta A, Sharma A. Gallbladder cancer: Progress in the Indian subcontinent. World J Clin Oncol 2024; 15(6): 695-716
- URL: https://www.wjgnet.com/2218-4333/full/v15/i6/695.htm
- DOI: https://dx.doi.org/10.5306/wjco.v15.i6.695